Claim library

Has FDA flagged "tirzepatide"?

Yes. FDA has quoted wording matching "tirzepatide" in at least 40 warning letters in our database. The most recent is FDA's August 24, 2026 letter to Peptide Partners LLC.

Checked against published FDA warning letters, updated November 15, 2026.

Letters that quote it

Each quote is copied from the company's marketing as FDA printed it in the letter.

This study shows that tirzepatide... has direct protective effects on the kidneys, which could be beneficial for patients with diabetic kidney disease.

Peptide Partners LLC, August 24, 2026
Read the FDA letter

Tirzepatide has become a major focus of metabolic, endocrinology, obesity, and peptide science due to its unique activity at both the GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.

Royal Peptides LLC, August 24, 2026
Read the FDA letter

Tirzepatide is the active ingredient in Mounjaro® and Zepbound®

FITISH, June 8, 2026
Read the FDA letter

Semaglutide & Tirzepatide is the active ingredient used in FDA-Approved weekly injection Wegovy® and Mounjaro….

Altru Telehealth, LLC dba Altru Telehealth, June 8, 2026
Read the FDA letter

Ozempic, Mounjaro, and Wegovy contain the same active ingredients as our compounded versions (semaglutide and tirzepatide).

Amie Health, Inc. dba Amie, June 8, 2026
Read the FDA letter

Our platform provides seamless access to advanced GLP-1 medications, such as compounded Semaglutide (found in Ozempic® and Wegovy®) and Tirzepatide (found in Mounjaro® and Zepbound™)…

Momentum Health 360 dba Momentum Health, June 8, 2026
Read the FDA letter

Application: Functionally, Tirzepatide stimulates insulin release from the pancreas and reduces hyperglycemia.

Prime Sciences, March 31, 2026
Read the FDA letter

GLP-2 TRZ (Tirzepatide) Uses: Weight Loss, Addiction Recovery Dosing: Start: 2.5mg weekly. Titrate up to: 15mg weekly.

Mile High Compounds LLC, March 31, 2026
Read the FDA letter

Tirzepatide (active ingredient used in Mounjaro®)

Premium Health Management Inc. dba Premium Health, February 20, 2026
Read the FDA letter

Compounded Tirzepatide (the same active ingredient as Mounjaro® & Zepbound®)

BluefitMD, February 20, 2026
Read the FDA letter

Tirzepatide is the active pharmaceutical ingredient in Mounjaro®* and Zepbound®*.

Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics, February 20, 2026
Read the FDA letter

Tirzepatide is the active ingredient in the brand medications Zepbound® and Mounjaro®.

Strut Health, LLC dba Strut, February 20, 2026
Read the FDA letter

Tirzepatide (Active Pharmaceutical Ingredient in Zepbound®)See Zepbound FDA Information

Kare Solutions, LLC dba Zappy, February 20, 2026
Read the FDA letter

semaglutide (active ingredient in Wegovy) or tirzepatide (active ingredient in Zepbound)

FitRX, LLC dba FitRx, February 20, 2026
Read the FDA letter

Tirzepatide (Mounjaro/Zepbound)

Master Pharmaceuticals Group, September 9, 2025
Read the FDA letter

Tirzepatide (similar to Mounjaro)

Nuvo Life Health Inc. dba Nuvo Life Health, September 9, 2025
Read the FDA letter

Showing the 20 most recent. See every match in the free check.

Why FDA quotes wording like this

Warning letters quote a company's own marketing as evidence of how a product is being sold. Under the Federal Food, Drug, and Cosmetic Act, a product promoted to cure, treat, mitigate or prevent disease is a drug, so disease claims on a supplement, CBD or wellness product can make it an unapproved drug. Some letters quote wording like "FDA approved" or "clinically proven" for other reasons. Each letter states its own charges, so read the source before deciding anything.

This page is informational and is not legal advice.

Is "tirzepatide" anywhere on your website?

FDA letters quote blog posts, FAQ answers and social captions, not just product pages. Our $39.99 report checks every page of your site against every letter in our database, with a link to each match.